PBS approval for new once-a-day diabetes medications 9 December 2014 New once-a-day fixed-dose medications for people with type 2 diabetes have been approved for inclusion on the Pharmaceutical Benefits Scheme (PBS). The two new treatments are linagliptin with metformin (sold as Trajenta Duo), and saxagliptin with metformin (sold as Kombiglyze). Federal Health Minister Peter Dutton said that while people with type 2 diabetes already have access to the individual medications through the PBS, some need to use a combination of medicines to treat their diabetes. “With the combination dose now listed on the PBS, these patients will save up to $36.90 every time they get a script filled because they will only have to buy one fixed dose medicine instead of two,†Mr Dutton said. The new treatments are available via prescription. For more information, please contact your doctor or endocrinologist.
Media releases 20 July 2024 Expert modelling shows huge cost savings for diabetes technology New research shows continuous glucose monitoring devices can dramatically reduce the risk of life-threatening diabetes-related complications including blindness, cardiovascular disease... Continue Reading
Media releases 18 July 2024 Uniting for technology access for Aboriginal and Torres Strait Islander people Diabetes Australia is calling on the government to support access to life-changing diabetes technology for Aboriginal and Torres Strait Islander... Continue Reading
Blog 18 July 2024 Cheryl’s story Cheryl’s journey with type 2 diabetes began 15 years ago when she was diagnosed unexpectedly during a routine blood test. “It turned my world upside down." Continue Reading